Placental stem cells are a powerful, ethically favorable source of multipotent stem cells (HSCs and MSCs) from a baby’s placenta, offering regenerative potential for various diseases like neurological, autoimmune, and heart conditions, with advantages including easy collection, high proliferation, and immune tolerance, currently undergoing research for tissue repair, organ regeneration, and treating injuries, though not yet FDA-approved as unlicensed drugs.